POLYRIZON LTD. (PLRZ)
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
Net Asset Value(s)
Immediate Report
RoboStrategy, Inc. Raises Approximately $33.9 Million Through Private Share Issuances
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
Playboy Joins Small-Cap Russell 2000® Index and Broad-Market Russell 3000® Index
AIB Data Centers Added to Russell Microcap® Index
ESS Added to Russell Microcap® Index
Kopin Secures Multiple Orders for Sentinel FPV™ Prototypes as Drone Dominance Program Accelerates